Results · Apr-Jun 2026
Dr. Reddy's Laboratories Q1 FY27 results
Sales fell 6% to ₹8,100 crore from ₹8,572 crore in Apr-Jun 2025.
Operating profit fell 60% to ₹860 crore, an operating margin of 10.6% (down 14.7 points from a year ago).
Net profit fell 69% to ₹436 crore from ₹1,410 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +7%, net profit +97%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 8,100 | 8,572 | −6% |
| Operating profit (EBITDA) | 859.9 | 2,174 | −60% |
| Operating margin | 10.6% | 25.4% | −14.7 pts |
| Net profit | 435.6 | 1,410 | −69% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.